Literature DB >> 14497198

Treatment of anxiety states by antidepressant drugs.

W SARGANT, P DALLY.   

Abstract

Entities:  

Keywords:  ANXIETY/therapy; DEPRESSION/therapy; MONOAMINE OXIDASE INHIBITORS/therapy; TRANQUILIZING AGENTS/therapy

Mesh:

Substances:

Year:  1962        PMID: 14497198      PMCID: PMC1959288          DOI: 10.1136/bmj.1.5270.6

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  4 in total

1.  The prognosis for affective illness with overt anxiety.

Authors:  L WALKER
Journal:  J Neurol Neurosurg Psychiatry       Date:  1959-11       Impact factor: 10.154

2.  Indications for use of iproniazid in psychiatric practice.

Authors:  P J DALLY
Journal:  Br Med J       Date:  1958-06-07

3.  Depressive states: their aetiology and treatment.

Authors:  G GARMANY
Journal:  Br Med J       Date:  1958-08-09

4.  Some reflections on the nature of affective disorders, arising from the results of prefrontal leucotomy.

Authors:  M PARTRIDGE
Journal:  J Ment Sci       Date:  1949-10
  4 in total
  14 in total

1.  DRUGS FOR DEPRESSION.

Authors:  A D FORREST
Journal:  Br Med J       Date:  1964-09-19

2.  PSYCHIATRIC ASPECTS OF VENEREAL DISEASE.

Authors:  E C DE KITE; A GRIMBLE
Journal:  Br J Vener Dis       Date:  1963-09

3.  IMIPRAMINE AND "DRINAMYL" IN DEPRESSIVE ILLNESS: A COMPARATIVE TRIAL.

Authors:  E H HARE; C MCCANCE; W O MCCORMICK
Journal:  Br Med J       Date:  1964-03-28

4.  PHYSIOLOGICAL AND CLINICAL EFFECTS OF AMYLOBARBITONE SODIUM THERAPY IN PATIENTS WITH ANXIETY STATES.

Authors:  L WING; M H LADER
Journal:  J Neurol Neurosurg Psychiatry       Date:  1965-02       Impact factor: 10.154

5.  Psychological effects of medication. Differences between physicians as revealed by clinical trials.

Authors:  C R JOYCE
Journal:  Proc R Soc Med       Date:  1962-09

6.  Monoamine Oxidase Inhibitors in the Treatment of Anxiety.

Authors: 
Journal:  Can Med Assoc J       Date:  1962-04-21       Impact factor: 8.262

7.  Experimental anxiety and antidepressant drugs: the effects of moclobemide, a selective reversible MAO-A inhibitor, fluoxetine and imipramine in mice.

Authors:  L de Angelis
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

Review 8.  Psychotropic drugs.

Authors:  J Hinton
Journal:  Postgrad Med J       Date:  1968-04       Impact factor: 2.401

9.  Treatment of childhood depression with antidepressant drugs.

Authors:  E A Frommer
Journal:  Br Med J       Date:  1967-03-25

10.  MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine. A double blind placebo controlled study.

Authors:  I M van Vliet; H G Westenberg; J A Den Boer
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.